ASLAN Pharmaceuticals Limited Anteile 2011-2026 | ASLN

Anteile Jährlich ASLAN Pharmaceuticals Limited

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	38.4 M	32.5 M	29.9 M	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
38.4 M	29.9 M	33.6 M

Anteile anderer Aktien in der Pharmaeinzelhändler

Name	Anteile	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Aligos Therapeutics ALGS	9.88 M	$ 8.67	0.35 %	$ 85.7 M	USA
Allakos ALLK	86.8 M	-	-	$ 28.6 M	USA
Alterity Therapeutics Limited ATHE	2.41 B	$ 3.6	-1.64 %	$ 8.66 B	Australia
Aptinyx APTX	67.7 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	36.4 M	-	-13.39 %	$ 1.45 M	USA
Anavex Life Sciences Corp. AVXL	85.3 M	$ 3.27	4.98 %	$ 279 M	USA
I-Mab IMAB	220 M	-	-	$ 866 M	China
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Brainstorm Cell Therapeutics BCLI	9.27 M	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	84.2 M	-	-	$ 8.42 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
BioNTech SE BNTX	244 M	$ 99.34	2.73 %	$ 27.2 B	Germany
bluebird bio BLUE	110 M	-	-	$ 546 M	USA
Burford Capital Limited BUR	219 M	$ 4.72	5.23 %	$ 751 M	Britain
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
Cabaletta Bio CABA	100 M	$ 3.23	0.94 %	$ 325 M	USA
Amphastar Pharmaceuticals AMPH	46.7 M	$ 21.6	1.12 %	$ 1.01 B	USA
Checkpoint Therapeutics CKPT	39.7 M	-	-	$ 169 M	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Clearside Biomedical CLSD	61.8 M	-	-	$ 25.3 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	257 M	$ 1.54	4.76 %	$ 396 M	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	1.65 M	$ 3.05	4.45 %	$ 5.02 M	Israel
Aquestive Therapeutics AQST	107 M	$ 4.21	0.36 %	$ 450 M	USA
Arcutis Biotherapeutics ARQT	127 M	$ 25.33	5.01 %	$ 3.22 B	USA
Chimerix CMRX	88.6 M	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	34.4 M	-	-	$ 401 M	USA
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	66.4 M	$ 33.59	3.07 %	$ 2.23 B	USA
Autolus Therapeutics plc AUTL	266 M	$ 1.49	1.1 %	$ 397 M	Britain
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
Cidara Therapeutics CDTX	6.35 M	-	-	$ 1.41 B	USA
AVROBIO AVRO	44.3 M	-	1083.1 %	$ 745 M	USA
CNS Pharmaceuticals CNSP	443 K	$ 2.46	-1.99 %	$ 1.09 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	1.42 B	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
CTI BioPharma Corp. CTIC	115 M	-	-	$ 1.2 B	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany